Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Biolaser ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   3.5% 9.6% 5.5% 4.7% 6.5% 4.1% 7.7% 7.7%   Credit score (0-100)   54 25 40 45 36 49 32 32   Credit rating   BBB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   593 -10.4 318 614 -46.6 209 0.0 0.0   EBITDA   405 -211 318 614 -46.6 107 0.0 0.0   EBIT   405 -211 318 614 -46.6 107 0.0 0.0   Pre-tax profit (PTP)   405.4 -216.8 317.5 614.1 -46.9 98.0 0.0 0.0   Net earnings   316.2 -169.1 247.7 479.0 -36.6 82.5 0.0 0.0   Pre-tax profit without non-rec. items   405 -217 317 614 -46.9 98.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,188 1,019 1,116 1,288 745 827 702 702   Interest-bearing liabilities   117 126 88.5 19.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,504 1,353 1,440 1,601 995 1,136 702 702   Net Debt   -173 -489 -675 -996 -89.5 -86.4 -195 -195     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   593 -10.4 318 614 -46.6 209 0.0 0.0   Gross profit growth   106.1% 0.0% 0.0% 93.5% 0.0% 0.0% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,504 1,353 1,440 1,601 995 1,136 702 702   Balance sheet change%   32.6% -10.0% 6.4% 11.2% -37.8% 14.1% -38.2% 0.0%   Added value   405.4 -211.0 317.5 614.4 -46.6 106.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 507 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 -1.0 1.0 2.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   68.3% 2,031.7% 100.0% 100.0% 100.0% 51.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.7% -14.8% 22.7% 40.4% -3.6% 10.0% 0.0% 0.0%   ROI %   34.9% -17.2% 27.0% 48.9% -4.5% 13.6% 0.0% 0.0%   ROE %   30.7% -15.3% 23.2% 39.9% -3.6% 10.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   79.0% 75.3% 77.5% 80.4% 74.8% 72.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -42.7% 231.6% -212.5% -162.2% 191.9% -81.1% 0.0% 0.0%   Gearing %   9.8% 12.4% 7.9% 1.5% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.8% 0.0% 0.6% 3.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.2 3.2 3.2 3.5 0.4 0.5 0.0 0.0   Current Ratio   7.5 6.5 6.1 5.4 1.9 2.0 0.0 0.0   Cash and cash equivalent   289.7 614.9 763.3 1,015.3 89.5 86.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,299.7 1,140.3 1,199.1 1,301.5 237.1 316.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 -47 107 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 -47 107 0 0   EBIT / employee   0 0 0 0 -47 107 0 0   Net earnings / employee   0 0 0 0 -37 83 0 0